IOBT Retained Earnings from 2010 to 2024

IOBT Stock

USD 0.75 0.04 5.63%

IO Biotech Retained Earnings yearly trend continues to be comparatively stable with very little volatility. Retained Earnings are likely to outpace its year average in 2024. Retained Earnings is the cumulative amount of net income that IO Biotech retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2010-12-31

Previous Quarter

-263.8 M

Current Value

-250.6 M

Quarterly Volatility

85.8 M

Credit Downgrade

Yuan Drop

Covid

Check IO Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IO Biotech's main balance sheet or income statement drivers, such as Net Interest Income of 5 M, Depreciation And Amortization of 204.2 K or Interest Expense of 2.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.65. IOBT financial statements analysis is a perfect complement when working with IO Biotech Valuation or Volatility modules.

Check out the analysis of IO Biotech Correlation against competitors.

For more information on how to buy IOBT Stock please use our How to Invest in IO Biotech guide.

Latest IO Biotech's Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of IO Biotech over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. IO Biotech's Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IO Biotech's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (263.82 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

IOBT Retained Earnings Regression Statistics

	Arithmetic Mean	(73,364,993)
	Coefficient Of Variation	(116.91)
	Mean Deviation	67,335,057
	Median	(26,360,000)
	Standard Deviation	85,770,281
	Sample Variance	7356.5T
	Range	237.5M
	R-Value	(0.76)
	Mean Square Error	3287.7T
	R-Squared	0.59
	Significance	0.0009
	Slope	(14,669,190)
	Total Sum of Squares	102991.6T

IOBT Retained Earnings History

	2024	-250.6 M
	2023	-263.8 M
	2022	-177.7 M
	2021	-106.3 M
	2020	-38.4 M

Other Fundumenentals of IO Biotech

Retained Earnings Total Equity

IO Biotech Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Capital Surpluse
Total Assets		1.0	0.99	-0.42	-0.99	-0.79	0.97	0.64	-0.97	1.0	-0.42	1.0	0.49	1.0	-0.81	0.49	0.65	-0.42
Total Stockholder Equity	1.0		1.0	-0.41	-0.99	-0.78	0.98	0.63	-0.97	1.0	-0.41	1.0	0.48	1.0	-0.8	0.48	0.65	-0.41
Net Tangible Assets	0.99	1.0		-0.39	-0.98	-0.79	0.98	0.6	-0.96	0.99	-0.39	0.99	0.54	0.99	-0.79	0.54	0.68	-0.39
Current Deferred Revenue	-0.42	-0.41	-0.39		0.52	0.81	-0.47	0.23	0.45	-0.4	1.0	-0.42	-0.65	-0.41	0.51	-0.65	-0.57	1.0
Net Debt	-0.99	-0.99	-0.98	0.52		0.83	-0.96	-0.6	0.96	-0.99	0.52	-0.99	-0.5	-0.99	0.84	-0.5	-0.65	0.52
Retained Earnings	-0.79	-0.78	-0.79	0.81	0.83		-0.86	-0.08	0.79	-0.77	0.81	-0.78	-0.78	-0.77	0.79	-0.78	-0.9	0.81
Accounts Payable	0.97	0.98	0.98	-0.47	-0.96	-0.86		0.48	-0.98	0.98	-0.47	0.97	0.57	0.97	-0.78	0.57	0.79	-0.47
Net Receivables	0.64	0.63	0.6	0.23	-0.6	-0.08	0.48		-0.51	0.63	0.23	0.64	-0.23	0.66	-0.54	-0.23	-0.06	0.23
Total Liab	-0.97	-0.97	-0.96	0.45	0.96	0.79	-0.98	-0.51		-0.98	0.45	-0.97	-0.45	-0.96	0.69	-0.45	-0.69	0.45
Net Invested Capital	1.0	1.0	0.99	-0.4	-0.99	-0.77	0.98	0.63	-0.98		-0.4	1.0	0.47	1.0	-0.78	0.47	0.64	-0.4
Short Long Term Debt	-0.42	-0.41	-0.39	1.0	0.52	0.81	-0.47	0.23	0.45	-0.4		-0.42	-0.65	-0.41	0.51	-0.65	-0.57	1.0
Total Current Assets	1.0	1.0	0.99	-0.42	-0.99	-0.78	0.97	0.64	-0.97	1.0	-0.42		0.48	1.0	-0.81	0.48	0.64	-0.42
Capital Stock	0.49	0.48	0.54	-0.65	-0.5	-0.78	0.57	-0.23	-0.45	0.47	-0.65	0.48		0.46	-0.49	1.0	0.77	-0.65
Net Working Capital	1.0	1.0	0.99	-0.41	-0.99	-0.77	0.97	0.66	-0.96	1.0	-0.41	1.0	0.46		-0.82	0.46	0.63	-0.41
Short Term Debt	-0.81	-0.8	-0.79	0.51	0.84	0.79	-0.78	-0.54	0.69	-0.78	0.51	-0.81	-0.49	-0.82		-0.49	-0.67	0.51
Common Stock	0.49	0.48	0.54	-0.65	-0.5	-0.78	0.57	-0.23	-0.45	0.47	-0.65	0.48	1.0	0.46	-0.49		0.77	-0.65
Property Plant Equipment	0.65	0.65	0.68	-0.57	-0.65	-0.9	0.79	-0.06	-0.69	0.64	-0.57	0.64	0.77	0.63	-0.67	0.77		-0.57
Capital Surpluse	-0.42	-0.41	-0.39	1.0	0.52	0.81	-0.47	0.23	0.45	-0.4	1.0	-0.42	-0.65	-0.41	0.51	-0.65	-0.57

Click cells to compare fundamentals

About IO Biotech Financial Statements

IO Biotech shareholders use historical fundamental indicators, such as Retained Earnings, to determine how well the company is positioned to perform in the future. Although IO Biotech investors may analyze each financial statement separately, they are all interrelated. The changes in IO Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on IO Biotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Retained Earnings	-263.8 M	-250.6 M
Retained Earnings Total Equity	-160 M	-168 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for IOBT Stock Analysis

When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC